Our Noviplex cards have been relaunched and rebranded!
Visit our Telimmune™ website to learn more and purchase today.
SOLUTIONS
CONVERTING LCs INTO PROTEOFORM ANALYSIS PLATFORMS
New "Proteometer Kit" - Coming Fall 2022
NOVIPLEX™ PLASMA COLLECTION SOLUTIONS
(NOW TELIMMUNE)
Advanced Remote
Plasma Collection
Purchase at Telimmune.com
ENHANCED APPROACH TO PROCESS ANALYTICAL TECHNOLOGY
Save Time and Money With Mobile Affinity Sorbent Chromatography (MASC™)
ABOUT
Novilytic is a molecular recognition company that utilizes nanotechnology to protect lifesaving drugs.
Our flagship technology is The Proteometer, the world’s first instrument capable of Molecular Structure Analysis of proteoforms in process. It is a solution that can lead to increased FDA compliance while saving time and money.
We are currently developing Nanotechnology Kits that will turn a liquid chromatograph (LC) into a Proteometer capable of real-time proteoform analysis on post-translational modifications.
.
TESTIMONIALS
“The Proteometer is expected to play a central role in the development and commercialization of next-level biological manufacturing control strategies.
Eugene L. Inman, Ph.D.
Pharmaceutical Quality Consultant
Retired Eli Lilly and Company
“Novilytic’s Proteometer is a disruptive breakthrough that finally solves the FDA's requirement to continuously monitor t-mAb proteoforms during fermentation.”
Martin Long, BSc.
Performance Validation, Inc. – President & CEO
(Analytical Sciences Business, Brooks Life Sciences, Thermo, Perkin Elmer)
“We couldn’t be more thrilled by the results of our validation and stability analyses using the NoviPlex dry plasma cards and look forward to using them in our DMD clinical trial.”
Ines Macias-Perez, Ph.D
Principle Scientist, Product Development
Cumberland Pharmaceuticals
> 5,000
Bioreactors Globally
$8M
Raw Material Costs
0 PAT In-Line
Massive Industry Gap
The Proteometer Provides the Solution